Phase 1/2 Trial of Durvalumab and Lenalidomide in Patients with Cutaneous T Cell Lymphoma (CTCL): Preliminary Results of Phase I Results and Correlative Studies

导出原文传递

翻译打印收藏纠错

作者： Querfeld, Christiane ^[1] ; Zain, Jasmine M. ^[2] ; Wakefield, Devin L. ^[3] ; Jovanovic-Talisman, Tijana ^[4] ; Kil, Sung Hee ^[5] ; Estephan, Renee ^[6] ; Sanchez, James ; Palmer, Joycelynne ; Rosen, Steven T.

作者单位： City Hope Natl Med Ctr, Div Dermatol, Duarte, CA USA ^[1] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA USA ^[2] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplan, Duarte, CA USA ^[3] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA ^[4] City Hope Natl Med Ctr, Dept Informat Sci BRI, Duarte, CA USA ^[5] City Hope Natl Med Ctr, Toni Stephenson Lymphoma Ctr, Beckman Res Inst, Duarte, CA USA ^[6]

发布时间 2020-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交